Search the Newsreel

Treace Medical Concepts (TMCI) CEO John T. Treace reports 19.2% beneficial stake

John T. Treace, CEO of Treace Medical Concepts, has filed an amended Schedule 13G indicating a 19.2% beneficial ownership stake in the company, totaling 12,530,959 shares. This ownership includes direct holdings, shares in family trusts, his spouse's holdings, and stock options exercisable within 60 …

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50

Treace Medical Concepts (NASDAQ:TMCI) recently released its Q2 earnings, with revenues exceeding expectations at US$45m and statutory losses coming in smaller than anticipated at US$0.24 per share. Following the report, analysts increased their price target for TMCI to US$5.50, reflecting a moderate uplift in …

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Analysts

Analysts have issued a consensus "Reduce" rating for Treace Medical Concepts, Inc. (NASDAQ:TMCI), with an average 12-month price target of $5.17, despite the company beating recent quarterly revenue and EPS estimates. The stock opened at $4.67, and significant insider and institutional ownership is noted. …

Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial

Truist Financial has increased its price target for Treace Medical Concepts (NASDAQ:TMCI) from $4.00 to $5.00, while maintaining a "hold" rating, suggesting a potential upside of 10.13%. Despite this, the broader analyst consensus remains "Reduce" with a target of $5.17. The company recently reported …

Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating

Truist Securities has raised its price target for Treace Medical Concepts (TMCI) from $4 to $5, while maintaining a "Hold" rating on the stock. This adjustment comes after Treace Medical Concepts recently increased its earnings guidance for the full-year 2026. The medical technology company …

Treace Medical Concepts (TMCI) Stock Jumps As Cash Burn Eases But Sales Stall

Treace Medical Concepts (TMCI) saw its stock jump 8.7% despite essentially flat Q2 revenue of US$45.4m and a net loss of US$15.9m. Investors reacted positively to a smaller adjusted EBITDA loss and reduced cash burn, indicating a market preference for financial discipline over top-line …

Treace Medical Concepts, Inc. (TMCI) Stock Price, News, Quote & History

This page provides a comprehensive overview of Treace Medical Concepts, Inc. (TMCI) stock, including its current price, after-hours trading, historical data, and key financial metrics. It also features company news, analyst ratings, and a detailed description of its medical devices and technologies, such as …

Treace Medical Concepts: Q2 Earnings Snapshot

Treace Medical Concepts Inc. (TMCI) reported a second-quarter loss of $15.9 million, equating to 24 cents per share. The orthopedic medical device maker generated $45.4 million in revenue for the period and expects full-year revenue to be between $204 million and $212 million. This …

Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Treace Medical Concepts (NASDAQ:TMCI) announced its quarterly earnings, reporting an adjusted loss of $0.24 per share, surpassing the consensus estimate of a $0.30 loss, with revenues of $45.38 million beating the $44.02 million forecast. The company raised its 2026 revenue guidance to $204 million–$212 …

Treace Medical Concepts earnings beat by $0.06, revenue topped estimates

Treace Medical Concepts (NASDAQ: TMCI) reported a second-quarter EPS of $-0.24, surpassing the analyst estimate of $-0.30 by $0.06. The company's revenue for the quarter reached $45.4 million, exceeding the consensus estimate of $43.94 million. Despite a 117.91% increase in its stock price over …

Treace Medical Concepts Inc (TMCI) (Q2 2026) Earnings Call Highlights: Revenue Declines 4% but ...

Treace Medical Concepts Inc (TMCI) reported a 4% revenue decline to $45.4 million in Q2 2026, though adjusted EBITDA loss narrowed and cash usage significantly decreased. The company is experiencing increased adoption of new bunion systems and expects improved performance in the latter half …

Treace Medical Concepts Releases Q2 2026 Financial Results

Treace Medical Concepts, Inc. (TMCI) reported a narrower Q2 2026 loss per share of -$0.24, beating the -$0.30 estimate by 20.0%. The company's revenue for the quarter was $45.4 million, representing a 4.0% year-over-year decrease. Management projects full-year revenue to be between $204.0 million …

Treace Medical Concepts Inc (TMCI) Earnings Forecast: Future EPS & Revenue Growth Estimates

Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

Treace Medical Q2 revenue falls 4 percent to $45.4 million

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating Challenges with Innovative Medical Solutions

Treace Medical Concepts (TMCI) is a healthcare company innovating in bunion and foot deformity correction with products like the Lapiplasty System. Despite financial challenges including negative revenue growth and ROE, the company's unique product offerings present potential for investors. Its stock shows volatility, and …

About 40% of Treace’s Lapiplasty surgeon users use new systems

Treace Medical Concepts reported a 4% decline in Q2 2026 revenue to $45.4 million year-over-year, alongside a net loss of $15.9 million. Despite the revenue dip, the company saw an 8% reduction in operating expenses and significantly decreased year-to-date cash usage by 57%. Treace …

Securities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) Investors - Contact Levi & Korsinsky Before June 10, 2025

Levi & Korsinsky LLP has filed a class action securities lawsuit against Treace Medical Concepts, Inc. (NASDAQ:TMCI). The lawsuit alleges that the company made false statements and concealed information regarding competition and demand for its Lapiplasty product, leading to revenue decline. Investors who suffered …

Join Class Action to Recover Losses from Treace Medical Concepts

Levi & Korsinsky LLP has filed a class action securities lawsuit against Treace Medical Concepts, Inc. (TMCI) for alleged securities fraud between May 8, 2023, and May 7, 2024. The lawsuit claims that the company made false statements regarding competition impacting demand for its …

Treace Medical Concepts (TMCI) Expected to Post Earnings on Friday

Treace Medical Concepts (TMCI) is projected to release its Q2 2026 earnings before market open on Friday, August 7th, with analysts anticipating a loss of $0.30 per share and revenue of $44.02 million. Despite exceeding estimates in the previous quarter, the company remains unprofitable. …

Treace Medical Concepts Number of Employees 2026 | Employee Count & Headcount Data

Treace Medical Concepts, Inc. (TMCI) has approximately 444 total employees worldwide as of March 2026, a 2.3% decline from 2023. The company is actively hiring with 28 job postings in 2026, though this represents a 48.6% decline from 2025. Its workforce is concentrated in …

BlackRock (TMCI holder) files amended 13G showing 959,320 Treace Medical shares

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 959,320 shares in Treace Medical Concepts, Inc., which represents 1.5% of the outstanding common stock. This filing indicates that BlackRock holds sole voting and dispositive power over these shares. While various …

Treace Medical Concepts Inc (TMCI) Institutional Confidence

The article provides an analysis of the institutional confidence score for Treace Medical Concepts Inc (TMCI), which currently stands at 5.00, ranking 107 out of 199 in its industry. Institutional shareholding proportion decreased by 4.20% quarter-over-quarter to 58.61%. James Simons is highlighted as the …

TMCI|Treace Medical Concepts Inc|Price:4.030|Chg%:+0.020

This article provides a comprehensive stock analysis of Treace Medical Concepts Inc (TMCI) from TradingKey. It highlights the company's strong fundamentals and high growth potential, despite an average market performance in the last month. The analysis rates its valuation as "fairly valued" within the …

Treace Medical Concepts Inc (TMCI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Treace Medical Concepts Inc (TMCI) stock, focusing on its dividend and stock split history. It notes that the company has not distributed any dividends over the past five years. The page also presents current stock performance data, including …

Investors in Treace Medical Concepts, Inc. (TMCI): Protect Your Rights - Contact Levi & Korsinsky Before June 10, 2025

Levi & Korsinsky, LLP has announced a class action securities lawsuit against Treace Medical Concepts, Inc. (TMCI) for alleged securities fraud between May 8, 2023, and May 7, 2024. The lawsuit claims that the company made false statements and concealed that competition affected demand …

Treace Medical Concepts Inc (TMCI) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Treace Medical Concepts Inc (TMCI), covering operating, investing, and financing activities from FY2020Q1 to FY2026Q1. It breaks down various cash flow components such as net income, changes in working capital, capital expenditures, …

Treace Medical Concepts Inc Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article provides a revenue breakdown for Treace Medical Concepts Inc (TMCI), noting that relevant data for business segments, regional revenue, and profit contribution have not yet been disclosed by the company. It briefly presents the current stock price, market capitalization, and states that …

Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of Treace Medical Concepts, Inc. (TMCI) breached their fiduciary duties to shareholders. Long-term shareholders are encouraged to contact the firm to discuss potential corporate governance reforms, recovery of funds, or …

TradingKey

This article provides an income statement analysis for Treace Medical Concepts Inc (TMCI), detailing quarterly and annual financial performance metrics such as revenue, operating expenses, operating profit, and net income. It also includes FAQs explaining how to interpret the income statement, key metrics for …

Treace Medical Concepts, Inc. Revenue Breakdown – NASDAQ:TMCI

Treace Medical Concepts, Inc. (NASDAQ: TMCI) generated $212.69 million USD in revenue last year, primarily from its Medical Devices segment. This segment was also the top performer in the previous year, contributing $209.36 million USD. The vast majority of the company's revenue, $212.69 million …

Investors urged to act as law firm probes Treace Medical's board for possible breaches of duty.

Halper Sadeh LLC is investigating whether Treace Medical Concepts, Inc. officers and directors breached their fiduciary duties. The law firm is offering free consultations for long-term Treace stockholders who may seek reforms, financial awards, or other remedies. Shareholders are encouraged to act quickly due …

Treace Medical Concepts schedules Q2 earnings release and conference call

Treace Medical Concepts (NASDAQ: TMCI) will announce its Q2 2026 financial results before the market open on August 7, 2026. Following the release, company management will host an earnings conference call at 8:00 a.m. ET on the same day to discuss the results. Interested …